A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

NCT01216176 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Anastrozole
DRUG: AZD0530 (saracatinib)
DRUG: Placebo

Sponsor

Joyce Marie Slingerland, MD

Collaborators

[object Object]